As of 2025-06-22, the Intrinsic Value of WPD Pharmaceuticals Inc (WBIO.CN) is -0.01 CAD. This WBIO.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.19 CAD, the upside of WPD Pharmaceuticals Inc is -103.81%.
Based on its market price of 0.19 CAD and our intrinsic valuation, WPD Pharmaceuticals Inc (WBIO.CN) is overvalued by 103.81%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.01 - -0.01 | -0.01 | -103.81% |
| P/E | (0.03) - 0.07 | 0.03 | -84.9% |
| DDM - Stable | (0.02) - 0.80 | 0.39 | 104.9% |
| DDM - Multi | (0.28) - 7.49 | (0.58) | -404.2% |
| Market Cap (mil) | 0.88 |
| Beta | -0.17 |
| Outstanding shares (mil) | 4.64 |
| Enterprise Value (mil) | 1.26 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.10% |
| Cost of Debt | 5.00% |
| WACC | 5.48% |